|
C20ORF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.982500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.073220E-01 |
| Normal-vs-Stage2 |
8.022600E-01 |
| Normal-vs-Stage3 |
5.087800E-02 |
| Normal-vs-Stage4 |
2.987600E-02 |
| Stage1-vs-Stage2 |
2.437800E-01 |
| Stage1-vs-Stage3 |
6.356000E-01 |
| Stage1-vs-Stage4 |
3.016800E-01 |
| Stage2-vs-Stage3 |
1.986400E-01 |
| Stage2-vs-Stage4 |
1.121600E-01 |
| Stage3-vs-Stage4 |
5.933200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.876200E-02 |
| Normal-vs-AfricanAmerican |
7.836200E-01 |
| Normal-vs-Asian |
2.178200E-01 |
| Caucasian-vs-AfricanAmerican |
9.627700E-02 |
| Caucasian-vs-Asian |
7.478000E-01 |
| AfricanAmerican-vs-Asian |
2.604000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.370400E-02 |
| Normal-vs-Female |
1.152960E-01 |
| Male-vs-Female |
7.072600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.281360E-01 |
| Normal-vs-Age(41-60Yrs) |
2.212000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.216100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.736160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.057400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.220800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.179400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.095200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.617000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.485800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.576030E-03 |
| Classical-VS-Follicular |
5.084500E-03 |
| Classical-VS-Other |
2.740800E-01 |
| Classical-VS-Normal |
4.685600E-01 |
| Tall-VS-Follicular |
4.849400E-01 |
| Tall-VS-Other |
8.752600E-01 |
| Tall-VS-Normal |
3.079900E-03 |
| Follicular-VS-Other |
9.091200E-01 |
| Follicular-VS-Normal |
1.800180E-02 |
| Other-VS-Normal |
2.092600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.508020E-01 |
| Normal-vs-N1 |
5.976500E-04 |
| N0-vs-N1 |
1.486030E-02 |
|
|
